![John Kaufmann](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John Kaufmann
Financieel Directeur/CFO bij S1 BioPharma, Inc.
Profiel
John F.
Kaufmann is currently the Chief Financial Officer at S1 BioPharma, Inc. He completed his undergraduate degree at Dartmouth College and holds an MBA from Boston University.
Actieve functies van John Kaufmann
Bedrijven | Functie | Begin |
---|---|---|
S1 BioPharma, Inc.
![]() S1 BioPharma, Inc. Pharmaceuticals: MajorHealth Technology S1 BioPharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development of drugs for the treatment of sexual dysfunction in both women and men. Its product portfolio include Lorexy's, Orexa, S1B-307, and S1B-3006. The company was founded in 2008 and is headquartered in New York, NY. | Financieel Directeur/CFO | 12-04-2012 |
Opleiding van John Kaufmann
Boston University | Masters Business Admin |
Dartmouth College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
S1 BioPharma, Inc.
![]() S1 BioPharma, Inc. Pharmaceuticals: MajorHealth Technology S1 BioPharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development of drugs for the treatment of sexual dysfunction in both women and men. Its product portfolio include Lorexy's, Orexa, S1B-307, and S1B-3006. The company was founded in 2008 and is headquartered in New York, NY. | Health Technology |